SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-013419
Filing Date
2018-11-30
Accepted
2018-11-30 17:05:00
Documents
6
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 GENETHERA, INC. MARCH 31, 2018 10-Q genethera_10q-17541.htm 10-Q 397463
2 CERTIFICATE OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBAN exhibit_31-1.htm EX-31.1 17314
3 CERTIFICATE OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBAN exhibit_31-2.htm EX-31.2 18313
4 CERTIFICATE OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, A exhibit_32-1.htm EX-32.1 5802
5 CERTIFICATE OF THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, A exhibit_32-2.htm EX-32.2 5143
6 IMAGE genethera_10q-17541000.jpg GRAPHIC 3958
  Complete submission text file 0001654954-18-013419.txt   450755
Mailing Address 6860 BROADWAY UNIT B DENVER CO 80221
Business Address 6860 BROADWAY UNIT B DENVER CO 80221 3039550190
GENETHERA INC (Filer) CIK: 0001017110 (see all company filings)

IRS No.: 650622463 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27237 | Film No.: 181211865
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences